litlas
Log inCreate account

Paul D. Brown

Active 1988–2026

198
Papers
39,478
Citations
103
h-index
190
i10-index

Citations

Citations per year for Paul D. Brown1986: 1 citations1993: 6 citations1994: 1 citations1996: 2 citations1997: 2 citations1998: 1 citations2000: 2 citations2001: 3 citations2003: 9 citations2004: 20 citations2005: 23 citations2006: 54 citations2007: 87 citations2008: 126 citations2009: 146 citations2010: 128 citations2011: 157 citations2012: 164 citations2013: 158 citations2014: 236 citations2015: 251 citations2016: 310 citations2017: 356 citations2018: 311 citations2019: 1,250 citations2020: 1,479 citations2021: 1,378 citations2022: 1,177 citations2023: 870 citations2024: 1,494 citations2025: 614 citations2026: 22 citations1987–1992: no citations, so these years are not shown1995: no citations, so this year is not shown1999: no citations, so this year is not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,450 citing papers, 29.9% of this breakdownChina: 969 citing papers, 8.4% of this breakdownGermany: 736 citing papers, 6.4% of this breakdownItaly: 568 citing papers, 4.9% of this breakdownUnited Kingdom: 552 citing papers, 4.8% of this breakdownCanada: 548 citing papers, 4.8% of this breakdownFrance: 488 citing papers, 4.2% of this breakdownNetherlands: 450 citing papers, 3.9% of this breakdownSwitzerland: 376 citing papers, 3.3% of this breakdownJapan: 293 citing papers, 2.5% of this breakdownAustralia: 263 citing papers, 2.3% of this breakdownSpain: 260 citing papers, 2.3% of this breakdown
0%29.9%Other 22.3%

Institutions

Fields

  • Medicine76.8%
  • Biochemistry, Genetics and Molecular Biology10.1%
  • Neuroscience2.9%
  • Materials Science2.2%
  • Immunology and Microbiology1.8%
  • Engineering1.6%
  • Other4.6%

Topics

  • Glioma Diagnosis and Treatment15.8%
  • Brain Metastases and Treatment12%
  • Lung Cancer Research Studies4.1%
  • Meningioma and schwannoma management2.9%
  • Lung Cancer Treatments and Mutations2.4%
  • Management of metastatic bone disease2.1%
  • Other60.7%

Coauthors

All papers

Open in search
  1. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

    Authors: Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie L. Pugh, Minhee Won, Robert Jeraj, Paul D. Brown, Kurt A. Jaeckle, David Schiff, Volker W. Stieber, David Brachman, Maria Werner‐Wasik, Ivo W. Tremont‐Lukats, Erik P. Sulman, Kenneth Aldape, Walter J. Curran, Minesh P. Mehta - New England Journal of Medicine 2014 cited by 2,793

  2. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

    Authors: Michael A. Vogelbaum, Paul D. Brown, Hans Messersmith, Priscilla K. Brastianos, Stuart H. Burri, Daniel P. Cahill, Ian F. Dunn, Laurie E. Gaspar, Na Tosha Gatson, Vinai Gondi, Justin T. Jordan, Andrew B. Lassman, Julia Maués, Nimish Mohile, Navid Redjal, Glen Stevens, Erik P. Sulman, Martin J. van den Bent, H. James Wallace, Jeffrey S. Weinberg, Gelareh Zadeh, David Schiff - Journal of Clinical Oncology 2021 cited by 798

  3. Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

    Authors: Jann N. Sarkaria, Leland Hu, Ian F. Parney, Deanna Pafundi, Debra H. Brinkmann, Nadia N. Laack, Caterina Giannini, Terence Burns, Sani H. Kizilbash, Janice K. Laramy, Kristin R. Swanson, Timothy J. Kaufmann, Paul D. Brown, Nathalie Y.R. Agar, Evanthia Galanis, Jan C. Buckner, William F. Elmquist - Neuro-Oncology 2017 cited by 699

  4. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases

    Authors: Paul D. Brown, Kurt A. Jaeckle, Karla V. Ballman, Elana Farace, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Fred G. Barker, Richard L. Deming, Stuart H. Burri, Cynthia Ménard, Caroline Chung, Volker W. Stieber, Bruce E. Pollock, Evanthia Galanis, Jan C. Buckner, Anthony L. Asher - JAMA 2016 cited by 1,661

  5. Response assessment criteria for brain metastases: proposal from the RANO group

    Authors: Nancy U. Lin, Eudocia Q. Lee, Hidefumi Aoyama, Igor J. Barani, Daniel P. Barboriak, Brigitta G. Baumert, Martin Bendszus, Paul D. Brown, D. Ross Camidge, Susan M. Chang, Janet Dancey, Elisabeth G.E. de Vries, Laurie E. Gaspar, Gordon J. Harris, F. Stephen Hodi, Steven N. Kalkanis, Mark E. Linskey, David Macdonald, Kim Margolin, Minesh P. Mehta, David Schiff, Riccardo Soffietti, John H. Suh, Martin J. van den Bent, Michael A. Vogelbaum, Patrick Y. Wen - The Lancet Oncology 2015 cited by 1,088

  6. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

    Authors: Mark R. Gilbert, Meihua Wang, Kenneth Aldape, Roger Stupp, Monika E. Hegi, Kurt A. Jaeckle, Terri S. Armstrong, Jeffrey S. Wefel, Minhee Won, Deborah T. Blumenthal, Anita Mahajan, Christopher J. Schultz, Sara Erridge, Brigitta G. Baumert, Kristen I. Hopkins, Tzahala Tzuk-Shina, Paul D. Brown, Arnab Chakravarti, Walter J. Curran, Minesh P. Mehta - Journal of Clinical Oncology 2013 cited by 1,074

  7. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Authors: Paul D. Brown, Karla V. Ballman, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Anthony Whitton, Jeffrey Greenspoon, Ian F. Parney, Nadia N. Laack, Jonathan B. Ashman, Jean-Paul Bahary, Costas G. Hadjipanayis, James J. Urbanic, Fred G. Barker, Elana Farace, Deepak Khuntia, Caterina Giannini, Jan C. Buckner, Evanthia Galanis, David Roberge - The Lancet Oncology 2017 cited by 1,192

  8. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

    Authors: Paul D. Brown, Vinai Gondi, Stephanie L. Pugh, Wolfgang A. Tomé, Jeffrey S. Wefel, Terri S. Armstrong, Joseph Bovi, Clifford G. Robinson, André Konski, Deepak Khuntia, David R. Grosshans, Tammie L.S. Benzinger, Deborah Watkins Bruner, Mark R. Gilbert, David Roberge, Vijayananda Kundapur, Kiran Devisetty, Sunjay Shah, Kenneth Y. Usuki, Bethany Anderson, Baldassarre Stea, Harold Yoon, Jing Li, Nadia N. Laack, Tim J. Kruser, Steven J. Chmura, Wenyin Shi, Snehal Deshmukh, Minesh P. Mehta, Lisa A. Kachnic, for NRG Oncology - Journal of Clinical Oncology 2020 cited by 830

  9. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

    Authors: Paul W. Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin, Eric Nesbit, Tim J. Kruser, Jason W. Chan, Steve Braunstein, Jessica Lee, John P. Kirkpatrick, Will Breen, Paul D. Brown, Diana D. Shi, Helen A. Shih, Hany Soliman, Arjun Sahgal, Ryan Shanley, William Sperduto, Emil Lou, Ashlyn S. Everett, Drexell H. Boggs, Laura Masucci, David Roberge, Jill Remick, Kristin A. Plichta, John M. Buatti, Supriya Jain, Laurie E. Gaspar, Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, Yi An, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - Journal of Clinical Oncology 2020 cited by 467

  10. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

    Authors: Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh, Arnab Chakravarti, Mark R. Gilbert, Geoffrey Barger, Stephen W. Coons, Peter E. Ricci, Dennis E. Bullard, Paul D. Brown, K. Stelzer, David Brachman, John H. Suh, Christopher J. Schultz, Jean-Paul Bahary, Barbara J. Fisher, Harold Kim, Albert Murtha, Erica H. Bell, Minhee Won, Minesh P. Mehta, Walter J. Curran - New England Journal of Medicine 2016 cited by 1,044

  11. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial

    Authors: Anita Mahajan, Salmaan Ahmed, Mary Frances McAleer, Jeffrey S. Weinberg, Jing Li, Paul D. Brown, Stephen H. Settle, Sujit S. Prabhu, Frederick F. Lang, Nicholas B. Levine, Susan L. McGovern, Erik P. Sulman, Ian E. McCutcheon, Syed Azeem, Daniel P. Cahill, Claudio E. Tatsui, Amy B. Heimberger, Sherise D. Ferguson, Amol J. Ghia, Franco DeMonte, Shaan M. Raza, Nandita Guha‐Thakurta, James N. Yang, Raymond Sawaya, Kenneth R. Hess, Ganesh Rao - The Lancet Oncology 2017 cited by 781

  12. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline

    Authors: Vinai Gondi, Glenn Bauman, Lisa Bradfield, Stuart H. Burri, Daniel Cabrera, Danielle A. Cunningham, Bree R. Eaton, Jona A. Hattangadi‐Gluth, Michelle M. Kim, Rupesh Kotecha, Lianne Kraemer, Jing Li, Seema Nagpal, Chad G. Rusthoven, John H. Suh, Wolfgang A. Tomé, Tony J. C. Wang, Alexandra S. Zimmer, Mateo Ziu, Paul D. Brown - Practical Radiation Oncology 2022 cited by 376

  13. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

    Authors: Paul D. Brown, S. Pugh, Nadia N. Laack, Jeffrey S. Wefel, Deepak Khuntia, Christina Meyers, Ali Choucair, Sherry Fox, John H. Suh, David Roberge, Vivek S. Kavadi, Søren M. Bentzen, Minesh P. Mehta, Deborah Watkins Bruner, for the Radiation Therapy Oncology Group (RTOG) - Neuro-Oncology 2013 cited by 944

  14. Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

    Authors: Ayal A. Aizer, Nayan Lamba, Manmeet S. Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K. Brastianos, Paul D. Brown, D. Ross Camidge, Veronica Chiang, Michael A. Davies, Leland Hu, Raymond Y. Huang, Timothy J. Kaufmann, Priya Kumthekar, Keng Lam, Eudocia Q. Lee, Nancy U. Lin, Minesh P. Mehta, Michael Parsons, David A. Reardon, Jason P. Sheehan, Riccardo Soffietti, Hussein A. Tawbi, Michael Weller, Patrick Y. Wen - Neuro-Oncology 2022 cited by 192

  15. Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

    Authors: Paul W. Sperduto, Norbert Kased, David Roberge, Zhiyuan Xu, Ryan Shanley, Xianghua Luo, Penny K. Sneed, Samuel T. Chao, Robert J. Weil, John H. Suh, Amit Bhatt, Ashley W. Jensen, Paul D. Brown, Helen A. Shih, John P. Kirkpatrick, Laurie E. Gaspar, John B. Fiveash, Veronica Chiang, Jonathan Knisely, Christina Maria Sperduto, Nancy U. Lin, Minesh P. Mehta - Journal of Clinical Oncology 2011 cited by 1,420

  16. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases

    Authors: Timothy J. Kaufmann, Marion Smits, Jerrold L. Boxerman, Raymond Y. Huang, Daniel P. Barboriak, Michael Weller, Caroline Chung, Christina Tsien, Paul D. Brown, Lalitha Shankar, Evanthia Galanis, Elizabeth R. Gerstner, Martin J. van den Bent, Terry C. Burns, Ian F. Parney, Gavin P. Dunn, Priscilla K. Brastianos, Nancy U. Lin, Patrick Y. Wen, Benjamin M. Ellingson - Neuro-Oncology 2020 cited by 259

  17. Estimating Survival in Patients With Lung Cancer and Brain Metastases

    Authors: Paul W. Sperduto, Jonathan T. Yang, Kathryn Beal, Hubert Y. Pan, Paul D. Brown, Ananta Bangdiwala, Ryan Shanley, Norman Yeh, Laurie E. Gaspar, Steve Braunstein, Penny K. Sneed, John Boyle, John P. Kirkpatrick, Kimberley S. Mak, Helen A. Shih, Alex Engelman, David Roberge, Nils D. Arvold, Brian M. Alexander, Mark M. Awad, Joseph N. Contessa, Veronica Chiang, J. Hardie, J. Daniel, Emil Lou, William Sperduto, Minesh P. Mehta - JAMA Oncology 2016 cited by 658

  18. BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

    Authors: Priscilla K. Brastianos, Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Shervin Tabrizi, Brian Kabat, Julia Thierauf, Michael W. Ruff, Daniela A. Bota, David A. Reardon, Adam L. Cohen, Macarena I. de la Fuente, Glenn J. Lesser, Jian Campian, Pankaj K. Agarwalla, Priya Kumthekar, Bhupinder Mann, Shivangi Vora, Michael Knopp, A. John Iafrate, William T. Curry, Daniel P. Cahill, Helen A. Shih, Paul D. Brown, Sandro Santagata, Fred G. Barker, Evanthia Galanis - New England Journal of Medicine 2023 cited by 135

  19. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

    Authors: Priscilla K. Brastianos, Erin Twohy, Elizabeth R. Gerstner, Timothy J. Kaufmann, A. John Iafrate, Jochen K. Lennerz, Suriya Jeyapalan, David Piccioni, Varun Monga, Camilo E. Fadul, David Schiff, Jennie Taylor, Sajeel Chowdhary, Chetan Bettegowda, George Ansstas, Macarena I. de la Fuente, Mark D. Anderson, Nicole Shonka, Denise Damek, Jose Carrillo, Lara Kunschner Ronan, Rekha Chaudhary, Kurt A. Jaeckle, Francis M. Senecal, Thomas Kaley, Tara Morrison, Alissa A. Thomas, Mary Welch, Fábio M. Iwamoto, David Cachia, Adam L. Cohen, Shivangi Vora, Michael V. Knopp, Ian F. Dunn, Priya Kumthekar, Jann N. Sarkaria, Susan M. Geyer, Xiomara W. Carrero, Maria Martinez‐Lage, Daniel P. Cahill, Paul D. Brown, Caterina Giannini, Sandro Santagata, Frederick G. Barker, Evanthia Galanis - Journal of Clinical Oncology 2022 cited by 105

  20. Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

    Authors: Paul W. Sperduto, Samuel T. Chao, Penny K. Sneed, Xianghua Luo, John H. Suh, David Roberge, Amit Bhatt, Ashley W. Jensen, Paul D. Brown, Helen A. Shih, John P. Kirkpatrick, Amanda Schwer, Laurie E. Gaspar, John B. Fiveash, Veronica Chiang, Jonathan Knisely, Christina Maria Sperduto, Minesh P. Mehta - International Journal of Radiation Oncology*Biology*Physics 2009 cited by 985

  21. Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline

    Authors: Daniel Cabrera, John P. Kirkpatrick, John B. Fiveash, Helen A. Shih, Eugene J. Koay, Stephen Lutz, Joshua H. Petit, Samuel T. Chao, Paul D. Brown, Michael A. Vogelbaum, David A. Reardon, Arnab Chakravarti, Patrick Y. Wen, Eric L. Chang - Practical Radiation Oncology 2016 cited by 245

  22. Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

    Authors: Erica H. Bell, Jianwen Zhang, Edward G. Shaw, Jan C. Buckner, Geoffrey Barger, Dennis E. Bullard, Minesh P. Mehta, Mark R. Gilbert, Paul D. Brown, K. Stelzer, Joseph P. McElroy, Jessica L. Fleming, Cynthia Timmers, Aline Paixão Becker, Andrea L. Salavaggione, Ziyan Liu, Kenneth Aldape, David Brachman, Stanley Z. Gertler, Albert Murtha, Christopher J. Schultz, David W. Johnson, Nadia N. Laack, G.K. Hunter, Ian Crocker, Minhee Won, Arnab Chakravarti - Journal of Clinical Oncology 2020 cited by 222

  23. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons

    Authors: Radhe Mohan, Amy Liu, Paul D. Brown, Anita Mahajan, Jeffrey Dinh, Caroline Chung, Sarah McAvoy, Mary Frances McAleer, Steven H. Lin, Jing Li, Amol J. Ghia, Cong Zhu, Erik P. Sulman, John de Groot, Amy B. Heimberger, Susan L. McGovern, Clemens Grassberger, Helen A. Shih, Susannah G. Ellsworth, David R. Grosshans - Neuro-Oncology 2020 cited by 149

  24. A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma

    Authors: Paul D. Brown, Caroline Chung, Diane D. Liu, Sarah McAvoy, David R. Grosshans, Karine A. Al Feghali, Anita Mahajan, Jing Li, Susan L. McGovern, Mary-Fran McAleer, Amol J. Ghia, Erik P. Sulman, Marta Peñas-Prado, John de Groot, Amy B. Heimberger, Jihong Wang, Terri S. Armstrong, Mark R. Gilbert, Nandita Guha‐Thakurta, Jeffrey S. Wefel - Neuro-Oncology 2021 cited by 114